Thomas F. Goss
- Pharmacology top 0.5%
- Epidemiology top 5%
- Molecular Medicine top 0.5%
- Pulmonary and Respiratory Medicine top 10%
- Applied Microbiology and Biotechnology top 1%
- Co-authors
- Jerome J. SchentagDavid E. NixMary C. BirminghamAlan ForrestCharles H. BallowCharles F. ShieldDavid A. BuchnerJohn E. Ware
- Topics
- Health Systems, Economic Evaluations, Quality of Life (8 papers)Antibiotics Pharmacokinetics and Efficacy (8 papers)Hepatitis C virus research (6 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Thomas F. Goss
64 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Pharmacology 993
- Epidemiology 705
- Molecular Medicine 562
- Pulmonary and Respiratory Medicine 218
- Applied Microbiology and Biotechnology 198
Countries citing papers authored by Thomas F. Goss
This map shows the geographic impact of Thomas F. Goss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas F. Goss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas F. Goss more than expected).
Fields of papers citing papers by Thomas F. Goss
This network shows the impact of papers produced by Thomas F. Goss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas F. Goss. The network helps show where Thomas F. Goss may publish in the future.
Co-authorship network of co-authors of Thomas F. Goss
This figure shows the co-authorship network connecting the top 25 collaborators of Thomas F. Goss. A scholar is included among the top collaborators of Thomas F. Goss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas F. Goss. Thomas F. Goss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 5 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 6 | |
| 7 | 38 | |
| 8 | 1 | |
| 9 | 4 | |
| 10 | 42 | |
| 11 | 23 | |
| 12 | Clinical Characteristics and Impact of Neovascular Age–Related Macular Degeneration on Medical Status, Daily Living, Functioning, and Health Resource Utilization: A Survey of Five Countries | 2 |
| 13 | Humanistic Burden and Health Resource Utilization Among Neovascular Age–Related Macular Degeneration (AMD) Patients: Results from a Multi–Country Cross–Sectional Study | 1 |
| 14 | 28 | |
| 15 | 4 | |
| 16 | 7 | |
| 17 | 81 | |
| 18 | 1 | |
| 19 | 15 | |
| 20 | 10 |
About Thomas F. Goss
Thomas F. Goss is a scholar working on Applied Microbiology and Biotechnology, Hepatology and Transplantation, having authored 68 papers that have together received 2.2k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (8 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Hepatitis C virus research (6 papers). The work is most often cited by research in Molecular Medicine (562 citations), Applied Microbiology and Biotechnology (198 citations) and Pharmacology (993 citations). Thomas F. Goss has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Jerome J. Schentag, David E. Nix, Mary C. Birmingham, Alan Forrest, Charles H. Ballow, Charles F. Shield, David A. Buchner, John E. Ware, Martha Bayliss and Deborah Buchner. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.